Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Mabs|March 12, 2011
Rational engineering of antibody therapeutics targeting multiple oncogene pathwaysJonathan Fitzgerald, Alexey Lugovskoy
Plos One|May 30, 2008
DNA methylation causes predominant maternal controls of plant embryo growthJonathan FitzGerald, Ming Luo, Abed Chaudhury, et al.
BMJ Case Reports|December 2, 2011
Hypothyroidism presenting with recurrent pericardial tamponadeStephen Arthur, Gailash Beeharry-Panray, Jonathan Fitzgerald, et al.
EJNMMI Research|October 21, 2015
Longitudinal tumor hypoxia imaging with [(18)F]FAZA-PET provides early prediction of nanoliposomal irinotecan (nal-IRI) treatment activityJinzi Zheng, Stephan G Klinz, Raquel De Souza, et al.
Molecular Pharmaceutics|July 31, 2018
Liposomal Irinotecan Achieves Significant Survival and Tumor Burden Control in a Triple Negative Breast Cancer Model of Spontaneous MetastasisNicholas Bernards, Manuela Ventura, Inga B Fricke, et al.
Theranostics|May 4, 2018
Companion Diagnostic 64Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer NanomedicinesHelen Lee, Daniel Gaddy, Manuela Ventura, et al.
Mabs|February 9, 2013
Rapid optimization and prototyping for therapeutic antibody-like moleculesLihui Xu, Neeraj Kohli, Rachel Rennard, et al.
Cancer Research|December 1, 2017
Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug DeliveryHuang-Chiao Huang, Imran Rizvi, Joyce Liu, et al.
NPJ Systems Biology and Applications|July 21, 2017
Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121)Birgit Schoeberl, Art Kudla, Kristina Masson, et al.
Science Translational Medicine|September 13, 2021
Chromosomal instability sensitizes patient breast tumors to multipolar divisions induced by paclitaxelChristina M Scribano, Jun Wan, Karla Esbona, et al.
Pageof 2